CNS Pharmaceuticals(CNSP)

0.2044 -0.0096 -4.486%

今开:0.2146昨收:0.214
最高:0.2146 最低:0.1954
涨停价:0.0跌停价:0.0
总市值:2173780.0

CNS Pharmaceuticals的热门讨论

首次持股声明

CNS Pharmaceuticals(CNSP)02-06 23:35

$CNS Pharmaceuticals(CNSP)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001683168-24-000704  Size: 2 KB 网页链接查看全文

持股变动声明

CNS Pharmaceuticals(CNSP)04-11 09:55

$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002286  Size: 7 KB 网页链接查看全文

其他

CNS Pharmaceuticals(CNSP)03-29 05:35

$CNS Pharmaceuticals(CNSP)$ PRE 14A Other preliminary proxy statements Accession Number: 0001683168-24-001829  Act: 34  Size: 517 KB 网页链接查看全文

股东委托书协议

CNS Pharmaceuticals(CNSP)04-10 18:05

$CNS Pharmaceuticals(CNSP)$ DEF 14A Other definitive proxy statements Accession Number: 0001683168-24-002244  Act: 34  Size: 1 MB 网页链接查看全文

当期报告

CNS Pharmaceuticals(CNSP)04-15 18:15

$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001683168-24-002359  Act: 34  Size: 4 MB 网页链接查看全文

超过5%股东持股披露「修订」

CNS Pharmaceuticals(CNSP)02-15 03:35

$CNS Pharmaceuticals(CNSP)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-24-001223  Act: 34  Size: 90 KB 网页链接查看全文

持股变动声明

CNS Pharmaceuticals(CNSP)02-06 23:35

$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-000709  Size: 5 KB 网页链接查看全文

生效批准

CNS Pharmaceuticals(CNSP)01-30 19:05

$CNS Pharmaceuticals(CNSP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000237  Act: 33  Size: 1 KB 网页链接查看全文

持股变动声明

CNS Pharmaceuticals(CNSP)04-11 09:55

$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002290  Size: 7 KB 网页链接查看全文

持股变动声明

CNS Pharmaceuticals(CNSP)04-11 09:55

$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002283  Size: 7 KB 网页链接查看全文

1 2 3

CNS Pharmaceuticals的最新讨论

mx在隔壁2023-05-20 05:27

$CNS Pharmaceuticals(CNSP)$ 老妖复活,动力不弱查看全文

产业链观察2021-06-30 05:34

药闻| 2021年6月29日, 专门开发针对脑部原发性和转移性癌症的新疗法和中枢神经系统d的生物制药公司$CNS Pharmaceuticals(CNSP)$ 今天宣布美国食品和药物管理局 (FDA) 为其主要研究药物 Berubicin 授予快速通道指定,用于治疗复发性多形性胶质母细胞瘤 (GBM) 适应症。查看全文

修炼中的Jessie2021-02-10 21:15

赛选几轮后,Mark一下建仓的药股们,剩下的就留给时间吧。$CNS Pharmaceuticals(CNSP)$ $Applied Genetic(AGTC)$ $Surface Oncology(SURF)$ VXRT查看全文

Linktu2020-12-23 20:57

$CNS Pharmaceuticals(CNSP)$ 挂单1.9博反弹 [为什么]查看全文

皮神超级欧2020-12-19 04:59

$CNS Pharmaceuticals(CNSP)$ 这走势复刻昨天啊,莫非周一盘前也要暴涨?查看全文

皮神超级欧2020-12-19 00:23

$CNS Pharmaceuticals(CNSP)$ 因为要出门早上设了个3.4就没去管了。虽然盘前到了4.5,但是我不贪心,这周完美收局。查看全文

皮神超级欧2020-12-18 04:54

$CNS Pharmaceuticals(CNSP)$ 2.3补了一仓,2.5清了一半,剩下的留下了过年[斜眼]哈哈哈,别到时候bxrx那样崩了呀[抠鼻]查看全文

1 2

CNS Pharmaceuticals的公告

持股变动声明

$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-000709  Size: 5 KB 网页链接

持股变动声明

$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-000708  Size: 9 KB 网页链接

当期报告

$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 1.01, 5.02, and 9.01 Accession Number: 0001683168-24-000660  Act: 34  Size: 1 MB 网页链接

招股说明书

$CNS Pharmaceuticals(CNSP)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0001683168-24-000580  Act: 33  Size: 1 MB 网页链接

生效批准

$CNS Pharmaceuticals(CNSP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000237  Act: 33  Size: 1 KB 网页链接

当期报告

$CNS Pharmaceuticals(CNSP)$ 8-K Current report, item 5.02 Accession Number: 0001683168-24-000393  Act: 34  Size: 202 KB 网页链接

招股说明书「补充」

$CNS Pharmaceuticals(CNSP)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001683168-24-000358  Act: 33  Size: 4 MB 网页链接

招股说明书「补充」

$CNS Pharmaceuticals(CNSP)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001683168-24-000182  Act: 33  Size: 3 MB 网页链接

当期报告

$CNS Pharmaceuticals(CNSP)$ 8-K Current report, item 7.01 Accession Number: 0001683168-23-009006  Act: 34  Size: 201 KB 网页链接

当期报告

$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001683168-23-008901  Act: 34  Size: 230 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20